Загрузка...
Emerging Pharmacotherapies for Diabetic Macular Edema
Diabetic macular edema (DME) remains an important cause of visual loss in patients with diabetes mellitus. Although photocoagulation and intensive control of systemic metabolic factors have been reported to achieve improved outcomes in large randomized clinical trials (RCTs), some patients with DME...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299388/ https://ncbi.nlm.nih.gov/pubmed/22474425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/548732 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|